Judy J. Robertson Email and Phone Number
Judy J. Robertson work email
- Valid
- Valid
- Valid
Judy J. Robertson personal email
- Valid
Judy J. Robertson phone numbers
Accomplished, driven and high-energy biotech / pharmaceutical C-Suite executive leader with a track record for building, transforming and accelerating early to late-stage life science brands and portfolios. Adept at driving exceptionally successful global and USA commercial brand results across the pre–launch, launch to lifecycle management spectrum. Consistently exceeding expectations. Exemplary track record for assembling high-performing teams and organizationsAreas of Life Science Expertise • Global and US-based Commercialization • Country General Management - Canada• Product, Portfolio and Pipeline Strategy • Executive Marketing and Sales Leadership• BD&L and M&A• P & L Management• Market AccessDisease Area Expertise• Ophthalmology• Immunology• Cardiovascular• Respiratory• Dermatology• Gastroenterology• Small and Large Molecules
-
Board Member - Chair Of Nominating And Governance CommitteeDurect Corporation (Nasdaq - Dur) Apr 2019 - Present• Provide financial, strategic and commercial oversight for a novel epigenetic treatment for Alcoholic Hepatitis.• Chair of the Nominating and Governance committee / Member Audit Committee
-
Chief Commercial OfficerOpthea Jan 2022 - Oct 2024South Yarra, Vic, Au• Stepped off the BOD to lead the USA pre – commercialization strategy and tactics for the first and only VEGF C&D TRAP inhibitor in wet AMD that has shown superior visual acuity outcomes in combination with standard of care anti-VEGF-A. • Built and executed the strategic. market-shaping and tactical commercialization plan to maximize the full potential of sozinibercept in the USA.• Created very significant presence and equity for Opthea and sozinibercept within the retina specialist community within the USA and the EU. • Developed and represented the sozinibercept extraordinary commercial value proposition and plan to potential investors and partners. -
Member Board Of DirectorsOpthea Jun 2021 - Jan 2022South Yarra, Vic, Au• Oversight responsibility to ensure corporate, financial, strategic and particularly commercial deliverables were attained for Opthea and sozinibercept
-
Chief Commercial OfficerAerie Pharmaceuticals Dec 2016 - Jan 2019• US and Global responsibility to build the commercial organization. Created and executed the strategic commercialization plant go-to-market strategy to launch the 1st novel mechanism of action Rho kinase Inhibitor, Rhopressa in Glaucoma in 20 years in 2018.• Simultaneously prepared for the blockbuster scale near term launch of Rocklatan; the novel and powerful PGA + Rho kinase Inhibitor. • Built and led 150-person commercial organization and deployed a strong and successful go-to-market commercial strategy and execution; tracked as the best glaucoma launch in the last 10 years.
-
Vice President - Global Commercial - Immunology / OphthalmologyJanssen, Pharmaceutical Companies Of Johnson And Johnson Jun 2013 - Nov 2016Raritan, New Jersey, Us• Global responsibility for the near mid and long-term sustainable growth of the $10 billion Immunology Franchise: Rheumatoid Arthritis, Inflammatory Bowel Disease, Psoriasis and Pulmonary. • Lead a multi-disciplinary team (45) Global Strategic Marketing, Market Access, Medical Affairs, Commercial & Strategic Operations, Global Analytics and BD&L. • Significantly re-engineered the disease, portfolio and asset strategies.• Overhauled BD and MA search/evaluation strategy; reviewed over 75 assets, 12 under review and seven mid-size deals done. • Commercial team Global Leader for a novel Geographic Atrophy treatment and lead the cross-sector team to build a corporate strategy for Johnson and Johnson to enter the ophthalmology / retina disease area -
Global Business Franchise Head, OphthamologyAlcon Oct 2011 - Jun 2013• Global Business Franchise Head responsible for the near and long-term development and growth of the Rx franchise (4.0 bn); in particular Glaucoma, Retina, Dry Eye and Anti Inflammatory and Anti Infective.• Responsible for the directing and informing the disease area, portfolio and global commercial and development strategies of the in-line, pipeline and BD&L/M&A initiatives. -
Global Business Franchise Head, RespiratoryNovartis 2007 - 2011Basel, Baselstadt, Ch• Built and led the Global Novartis Asthma, Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) portfolio. Catapulted 10 dynamic products through Phase 2 and Phase 3 development. • Global commercial responsibility for pipeline success of early (POC) to late stage (LCM) Respiratory portfolio.• Championed the compelling Respiratory franchise opportunity throughout corporate, regions and countries. • Successfully launched a novel COPD brand, Onbrez, and Tobihaler, and prelaunch readied combination Ultibro Breezhaler and COPD assets.• Managed four strategic partnerships (i.e., Schering Plough/Genentech) to success or dissolution. -
Vp Marketing And Sales Respiratory And DermatologyNovartis Usa 2006 - 2007Marketing and Sales Management responsibility for the Respiratory and Derm Franchise.
-
President/General Manager - CanadaBristol-Myers Squibb 2004 - 2006Lawrence Township, Nj, Us• Led $550M business to double digit profitability through growth and innovation. Maximized value of drivers through strengthened commercial innovation and sales excellence.• Improved profitability 10% through resource allocation, restructuring and productivity initiatives.• Mobilized organization around execution of “Strategic Map” Balanced Scorecard approach to driving strategy.• Participated on R & D Canadian Pharmaceutical committee; led subgroup to challenge government drug approval and pricing roadblocks -
Vp Marketing Us - PlavixBristol-Myers Squibb 2002 - 2004Lawrence Township, Nj, Us
-
National Vp Hospital And Institutional SalesBristol-Myers Squibb 2001 - 2002Lawrence Township, Nj, Us
Judy J. Robertson Skills
Judy J. Robertson Education Details
-
Northwestern University - Kellogg School Of ManagementGeneral
Frequently Asked Questions about Judy J. Robertson
What company does Judy J. Robertson work for?
Judy J. Robertson works for Durect Corporation (Nasdaq - Dur)
What is Judy J. Robertson's role at the current company?
Judy J. Robertson's current role is Chief Commercial Officer / Board of Directors Executive.
What is Judy J. Robertson's email address?
Judy J. Robertson's email address is ju****@****tis.com
What is Judy J. Robertson's direct phone number?
Judy J. Robertson's direct phone number is +178728*****
What schools did Judy J. Robertson attend?
Judy J. Robertson attended Northwestern University - Kellogg School Of Management.
What skills is Judy J. Robertson known for?
Judy J. Robertson has skills like Pharmaceutical Industry, Global Marketing, Strategic Planning, Product Launch, Managed Care, Healthcare, Restructuring, Commercialization, Market Access, Sales Management, Business Planning, Cross Functional Team Leadership.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial